Literature DB >> 21659539

CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.

Julia Sáez de Guinoa1, Laura Barrio, Mario Mellado, Yolanda R Carrasco.   

Abstract

Continuous migration of B cells at the follicle contrasts with their stable arrest after encounter with antigen. Two main ligand/receptor pairs are involved in these cell behaviors: the chemokine CXCL13/chemokine receptor CXCR5 and antigen/BCR. Little is known regarding the interplay between CXCR5 and BCR signaling in the modulation of B-cell dynamics and its effect on B-cell activation. We used a 2-dimensional model to study B-cell migration and antigen recognition in real time, and found that BCR signaling strength alters CXCL13-mediated migration, leading to a heterogeneous B-cell behavior pattern. In addition, we demonstrate that CXCL13/CXCR5 signaling does not impair BCR-triggered immune synapse formation and that CXCR5 is excluded from the central antigen cluster. CXCL13/CXCR5 signaling enhances BCR-mediated B-cell activation in at least 2 ways: (1) it assists antigen gathering at the synapse by promoting membrane ruffling and lymphocyte function-associated antigen 1 (LFA-1)-supported adhesion, and (2) it allows BCR signaling integration in motile B cells through establishment of LFA-1-supported migratory junctions. Both processes require functional actin cytoskeleton and non-muscle myosin II motor protein. Therefore, the CXCL13/CXCR5 signaling effect on shaping B-cell dynamics is an effective mechanism that enhances antigen encounter and BCR-triggered B-cell activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659539     DOI: 10.1182/blood-2011-01-332106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate.

Authors:  Phillip J Stewart-Hutchinson; Taylor P Szasz; Emily R Jaeger; Michael D Onken; John A Cooper; Sharon Celeste Morley
Journal:  J Leukoc Biol       Date:  2017-06-21       Impact factor: 4.962

Review 2.  How B cells capture, process and present antigens: a crucial role for cell polarity.

Authors:  Maria-Isabel Yuseff; Paolo Pierobon; Anne Reversat; Ana-Maria Lennon-Duménil
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

3.  Bi-ligand surfaces with oriented and patterned protein for real-time tracking of cell migration.

Authors:  Varadraj N Vernekar; Charles S Wallace; Mina Wu; Joshua T Chao; Shannon K O'Connor; Aimee Raleigh; Xiaji Liu; Jason M Haugh; William M Reichert
Journal:  Colloids Surf B Biointerfaces       Date:  2014-09-19       Impact factor: 5.268

4.  MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.

Authors:  Jian-Qin Li; Shao-Yan Hu; Zhao-Yue Wang; Jing Lin; Su Jian; Yong-Chao Dong; Xiao-Fang Wu; Dai Lan; Li-Juan Cao
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

5.  Quantitative analysis of B-lymphocyte migration directed by CXCL13.

Authors:  Xiaji Liu; Sreeja B Asokan; James E Bear; Jason M Haugh
Journal:  Integr Biol (Camb)       Date:  2016-08-01       Impact factor: 2.192

6.  TNF-α Contributes to Lymphoid Tissue Disorganization and Germinal Center B Cell Suppression during Intracellular Bacterial Infection.

Authors:  Maria Popescu; Berenice Cabrera-Martinez; Gary M Winslow
Journal:  J Immunol       Date:  2019-09-30       Impact factor: 5.422

7.  Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.

Authors:  Monika Michel; Ilka Wilhelmi; Astrid-Solveig Schultz; Marco Preussner; Florian Heyd
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

8.  IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.

Authors:  Erica Maria Pimenta; Saurav De; Ryan Weiss; Di Feng; Kelly Hall; Sarah Kilic; Gyan Bhanot; Shridar Ganesan; Sophia Ran; Betsy J Barnes
Journal:  Immunol Cell Biol       Date:  2014-12-23       Impact factor: 5.126

9.  Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin.

Authors:  Neetha Parameswaran; Gospel Enyindah-Asonye; Nayer Bagheri; Neilay B Shah; Neetu Gupta
Journal:  J Immunol       Date:  2013-01-21       Impact factor: 5.422

10.  CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

Authors:  Bridget Charbonneau; Alice H Wang; Matthew J Maurer; Yan W Asmann; Clive S Zent; Brian K Link; Stephen M Ansell; George J Weiner; Nazan Ozsan; Andrew L Feldman; Thomas E Witzig; Julie M Cunningham; Ahmet Dogan; Thomas M Habermann; Susan L Slager; Anne J Novak; James R Cerhan
Journal:  Cancer Immunol Immunother       Date:  2013-06-28       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.